AIC
FENC icon

AWM Investment Company’s Fennec Pharmaceuticals FENC Stock Holding History

AWM Investment Company’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.43M Buy
720,135
+8,266
+1% +$63.8K 0.49% 51
2025
Q4 		$5.48M Buy
+711,869
New +$5.84M 0.53% 54
2023
Q2 		– Sell
-47,600
Closed -$396K – 116
2023
Q1 		$396K Buy
+47,600
New +$441K 0.05% 109

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Potomac Capital Management New York $115M AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AWM Investment Company's FENC Position: Q1 2026 in Review

AWM Investment Company increased its Fennec Pharmaceuticals (FENC) stake by 1.2% in Q1 2026, buying an estimated $63.8K and bringing the position to 720,135 shares worth $4.43M. The position accounts for 0.49% of the portfolio, ranked #51.

AWM Investment Company first reported a position in FENC in Q1 2023 and has held it in 3 quarters since. The position peaked at $5.48M in Q4 2025. 90 funds tracked by Wall St. Rank hold FENC as of Q1 2026.

  • AWM Investment Company held 720,135 shares of Fennec Pharmaceuticals worth $4.43M as of Q1 2026.
  • AWM Investment Company bought 8,266 Fennec Pharmaceuticals shares in Q1 2026, an estimated $63.8K.
  • Fennec Pharmaceuticals made up 0.49% of AWM Investment Company's portfolio in Q1 2026, its #51 holding.
  • AWM Investment Company first reported a position in Fennec Pharmaceuticals in Q1 2023 and has held it in 3 quarters since.
  • AWM Investment Company's Fennec Pharmaceuticals position peaked at $5.48M in Q4 2025.
  • 90 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.